Tag: bioequivalence

Debunking the myth that generics contain less medication. Learn what the FDA's 80-125% bioequivalence rule really means for drug absorption, safety, and efficacy compared to brand names.

Learn how to effectively discuss generic medications with patients. This guide covers the science of bioequivalence, addresses common patient fears, and provides practical communication frameworks to improve adherence and save costs.

False advertising in generic drugs misleads patients, increases health risks, and violates federal law. Learn what’s allowed, what’s illegal, and how new FDA rules are cracking down on deceptive marketing.

Dissolution profile comparison is the key method regulators use to prove generic drugs work like brand-name versions. Learn how f2 scores, testing standards, and new technologies ensure generics are safe and effective.

IVIVC allows pharmaceutical companies to replace costly human bioequivalence studies with lab-based dissolution testing, saving millions per product. Learn how it works, why most submissions fail, and where the field is headed.